SCHEMBL7814534

SCHEMBL7814534

Cc1nc2ccc(-c3ccc4c(c3)CN(c3ncnc5c3CCC(C)(c3ccccc3)C5)CCO4)cc2[nH]1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 12/20 0.45
KIT P10721 2/20 0.33
SMN1; SMN2 Q16637 3/20 0.32
KDM4E B2RXH2 3/20 0.32
ALDH1A1 P00352 3/20 0.32
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
HPGD P15428 2/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
HCRTR1 O43613 1/20 0.32
NFKB1 P19838 1/20 0.32
STAT1 P42224 1/20 0.32
NFKB2 Q00653 1/20 0.32
RELA Q04206 1/20 0.32
POLB P06746 1/20 0.32
CYP1A2 P05177 2/20 0.31
CYP2D6 P10635 2/20 0.31
MAPT P10636 2/20 0.31
CYP2C19 P33261 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL858889 0.91 PIK3CA (0.36) PIK3CAKITSMN1; SMN2KDM4EALDH1A1
SCHEMBL856908 0.90 PIK3CA (0.46) PIK3CAKITALDH1A1CYP1A2CYP2D6
SCHEMBL3806412 0.86 PIK3CA (0.47) PIK3CAKITALDH1A1CYP1A2CYP2D6
SCHEMBL856219 0.86 PIK3CA (0.46) PIK3CAKITALDH1A1CYP1A2CYP2D6
SCHEMBL856402 0.84 PIK3CA (0.49) PIK3CASMN1; SMN2KDM4EALDH1A1NPC1
SCHEMBL856858 0.82 PIK3CA (0.43) PIK3CASMN1; SMN2KDM4EALDH1A1NPC1
SCHEMBL856299 0.82 PIK3CA (0.47) PIK3CAKITSMN1; SMN2KDM4EALDH1A1
SCHEMBL858155 0.81 PIK3CA (0.37) PIK3CAKITKDM4EALDH1A1HPGD
SCHEMBL3755560 0.81 PIK3CA (0.46) PIK3CAKITALDH1A1CYP1A2CYP2D6
SCHEMBL858974 0.81 PIK3CA (0.46) PIK3CAKITALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010135568-A1 BENZOXAZEPINES AS INHIBITORS OF MTOR AND THEIR USE TO TREAT CANCER EXELIXIS, INC. (US) 2010-11-25 WO disclosed